Streetbeat News

CERO

CERo Therapeutics Holdings, Inc.

https://www.cero.bio

Industry

Biotechnology

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Bank of Marin Bancorp (NASDAQ:BMRC) shares fell sharply after reporting worse-than-expected quarterly earnings. Other notable stock movements include 2U, Inc. (NASDAQ:TWOU) climbing 128% and Cognition Therapeutics, Inc. (NASDAQ:CGTX) falling 34%.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 5:19 pm

U.S. stocks traded higher with the Nasdaq Composite gaining around 1%. McDonald's posted worse-than-expected Q2 results, leading to a decline in its stock. Lipella Pharmaceuticals, Planet Image International, and 2U, Inc. saw significant gains, while vTv Therapeutics, Cognition Therapeutics, and CERo Therapeutics experienced notable declines.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 2:12 pm

Pitney Bowes shares surged over 12% in pre-market trading after selling part of its e-commerce business to Stord. Other notable pre-market movers include Cognition Therapeutics, Longeveron, and Abbott Laboratories, among others.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 9:26 am

Edwards Lifesciences Corporation (NYSE:EW) shares fell sharply after reporting worse-than-expected Q2 sales and issuing weak Q3 guidance. Despite beating EPS estimates, the stock dipped 26.9%. The company also acquired JenaValve and Endotronix. Other notable movers include Predictive Oncology Inc. (NASDAQ:POAI), Psyence Biomedical Ltd. (NASDAQ:PBM), and Ford Motor Company (NYSE:F).

Portfolio Pulse from Avi Kapoor

July 25, 2024 | 6:12 pm

Indivior PLC (NASDAQ:INDV) shares surged 14.5% in pre-market trading after reporting better-than-expected Q2 earnings and announcing a $100 million share repurchase program. Other notable pre-market movers include Psyence Biomedical Ltd. (NASDAQ:PBM), BloomZ Inc. (NASDAQ:BLMZ), and 2U, Inc. (NASDAQ:TWOU), among others.

Portfolio Pulse from Avi Kapoor

July 25, 2024 | 10:36 am

The article highlights three oversold health care stocks with RSI values near or below 30, indicating potential buying opportunities. The stocks mentioned are Aslan Pharmaceuticals Ltd (NASDAQ:ASLN), CERo Therapeutics Holdings Inc (NASDAQ:CERO), and Organovo Holdings Inc (NASDAQ:ONVO).

Portfolio Pulse from Avi Kapoor

July 18, 2024 | 11:55 am

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) will present data on its lead compound CER-1236 at the Global Cell & Gene Therapy Summit 2024. The data supports the use of CER-1236 in treating acute myeloid leukemia (AML) and shows no adverse toxicities in healthy tissue. Initial human trials are anticipated upon IND clearance.

Portfolio Pulse from Benzinga Newsdesk

July 08, 2024 | 12:13 pm

The article highlights the performance of 12 health care stocks during Friday's after-market session. Notable gainers include Kineta (KA), iSpecimen (ISPC), ENDRA Life Sciences (NDRA), Brainstorm Cell (BCLI), Bullfrog AI Holdings (BFRG), and Can Fite Biofarma (CANF). On the losing side, Nexalin Technology (NXL), Scinai Immunotherapeutics (SCNI), Ontrak (OTRK), AN2 Therapeutics (ANTX), CERo Therapeutics Holdings (CERO), and Renovaro (RENB) saw declines.

Portfolio Pulse from Benzinga Insights

June 14, 2024 | 8:31 pm

Adobe Inc. (NASDAQ:ADBE) shares surged 14.6% in pre-market trading after reporting better-than-expected Q2 earnings and strong guidance. Other notable pre-market movers include FOXO Technologies Inc. (NYSE:FOXO), Chijet Motor Company, Inc. (NASDAQ:CJET), and Nauticus Robotics, Inc. (NASDAQ:KITT) among gainers, and Nexalin Technology, Inc. (NASDAQ:NXL) and Gain Therapeutics, Inc. (NASDAQ:GANX) among losers.

Portfolio Pulse from Avi Kapoor

June 14, 2024 | 12:19 pm

Signet Jewelers Limited (NYSE:SIG) shares fell over 12% due to mixed first-quarter earnings, including a significant drop in same-store sales. The company reported a 9.5% year-on-year sales decline, missing analyst estimates, but beat EPS expectations. Other stocks mentioned include BioRestorative Therapies, Zapp Electric Vehicles, Sharps Technology, and Broadcom, among others, with various gains and losses based on recent announcements and earnings reports.

Portfolio Pulse from Avi Kapoor

June 13, 2024 | 6:07 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.